Skip to main content
NASDAQ: ENTO
Entero Therapeutic

 

PRESS RELEASES
MEDIA

 

PRESS RELEASES

2025  
Title Date
Entero Regains Nasdaq Compliance With Grid AI Acquisition
30 October
Entero Therapeutics, Inc., Launches Grid AI Corp to Redefine How AI Infrastructure Connects to the Power Grid
16 October
ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand
01 October
2024

2023

 

2022

 

2021

 

2020

 

2019

 

2018

 

2017

 

2016

 

2015

 

2014

 

MEDIA

2024

 

TitleFormatDate
The Big Biz Show – Bob "Sully" Sullivan interviews James Sapirstein Video 25 July
Life Science Leader: Ben Comer Interviews James Sapirstein Article 28 June
Fierce Pharma: First Wave BioPharma comes ashore with new name as it prepares for phase 3 trial Article 17 May
The Big Biz Show – Bob "Sully" Sullivan interviews James Sapirstein Video 12 April
Investing in Stability: Q&A With James Sapirstein, CEO of First Wave BioPharma Article 13 March
The Big Biz Show – Bob "Sully" Sullivan interviews James Sapirstein Video 1 March
Benzinga: This BioPharma Could Be First To Market With Its Celiac Therapy – Phase 3 Clinical Trials To Commence In 2024 Article / Video 22 January

 
2023

 

TitleFormatDate
Benzinga: First Wave BioPharma To Acquire ImmunogenX To Bolster Gastrointestinal-Focused Pipeline Article 18 December
Business Insider: First Wave BioPharma To Acquire ImmunogenX In All-stock Transaction Article 18 December
Endpoints News: First Wave to merge with ImmunogenX Article 18 December
FierceBiotech: Fierce Biotech M&A Tracker 2023 Article 18 December
Scrip: First Wave To Merge With ImmunogenX With Focus On Celiac Disease Article 18 December
The Big Biz Show – Bob "Sully" Sullivan interviews James Sapirstein Video 28 November
The Big Biz Show – Bob "Sully" Sullivan interviews James Sapirstein Video 7 November
Benzinga: 'Transformative Event' For First Wave BioPharma: License Agreement for Hopeful Gastrointestinal Candidate From Sanofi Article 14 September
Endpoints News: First Wave licenses drug from Sanofi Article 14 September
Fierce Biotech: Sanofi Slings Long-Dormant Alzheimer’s Asset to First Wave for repurposing, secures buy back rights Article 14 September
Marketwatch: First Wave BioPharma stock soars in active trading after Sanofi license deal Article 14 September
Pharmaceutical Technology: First Wave plans to repurpose Sanofi’s capeserod as GI therapy Article 14 September
The Big Biz Show – Bob "Sully" Sullivan interviews James Sapirstein Video 22 August
The Big Biz Show – Bob "Sully" Sullivan interviews James Sapirstein Video 15 August
The Big Biz Show – Bob "Sully" Sullivan interviews James Sapirstein Video 16 June
Cystic Fibrosis News Today: Results from Phase 2 adrulipase trial for EPI expected next month Article 15 June
Cystic Fibrosis News Today: SPAN Phase 2 trial of adrulipase for EPI completes patient screening Article 15 May
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 02 May
Cystic Fibrosis News Today: Phase 2 trial of adrulipase in treating EPI tops 50% enrollment goal Article 02 May
Global Business Reports: Interview with James Sapirstein Article 17 March
Cystic Fibrosis News Today: Dosing begins in trial of adrulipase, yeast-derived enzyme for EPI Article 10 March
Cystic Fibrosis News Today: 1st CF patient screened Phase 2 trial of adrulipase to treat EPI Article 07 February
Cystic Fibrosis News Today: Patient Screening to Begin for Phase 2 Trial of Adrulipase Article 02 February
First Wave BioPharma Presentation – Sequire Biotechnology Conference ‘23 Video 02 February
Clinical Trials Arena: First Wave BioPharma to initiate trial of Adrulipase for Cystic Fibrosis Article 01 February
Scrip Asks…What Does 2023 Hold For Biopharma? Part 3: Global Headwinds Article 13 January

 
2022

 

TitleFormatDate
Sequire Spotlight Presents First Wave BioPharma (FWBI): Clinical Stage Biopharmaceuticals Video 22 December
Life Science Leader magazine interviews James Sapirstein Article 01 December
Impact Wealth: Impacting The BioPharma Industry With James Sapirstein Article 04 November
Fierce Biotech: First Wave signs up Rho for phase 2 trial of gastrointestinal drug Article 03 November
Cystic Fibrosis News Today: First Wave, Rho Team Up to Test New Adrulipase Treatment for CF Article 02 November
The Top 100 Innovators and Entrepreneurs Magazine Interviews James Sapirstein Article 25 October
Toni Loudenbeck of Traders News Source Interviews James Sapirstein CEO, First Wave BioPharma, Inc. Audio 6 October
Clinical Trial Guru interviews James Sapirstein Video 23 September
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 08 September
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 30 August
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 14 June
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 29 April
Medscape Education Issues Presentation on: “The Gastrointestinal System and COVID-19” Presentation 22 April
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 01 April
Global Business Reports – interview with James Sapirstein Article 22 March
BioTuesdays – First Wave developing targeted, non-systemic therapies for GI diseases Article 22 March
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 01 March
U.S. Pharmaceutical Industry Newsletter Article 18 February
Health Professional Radio: “Phase 2 RESERVOIR Study for COVID-GI Symptoms"  Podcast  09 February 
Health Professional Radio: “Phase 2 RESERVOIR Study for COVID-GI Symptoms"  Podcast  09 February 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein  Video  27 January 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein  Video  19 January 
New to the Street: Jane King Interviews James Sapirstein  Video  17 January 
The Bio Report – Repurposing A Drug For Parasitic Infections As A Targeted GI Therapy  Podcast  13 January 
First Wave BioPharma Files Two Provisional US Patent Applications For Adrulipase – Benzinga  Article  13 January 
EXCLUSIVE: First Wave BioPharma CEO Talks COVID-19 Trial – Benzinga  Article / Video  06 January 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein  Video 06 January 
2021

 

TitleFormatDate
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 02 December 
The Clinical Research Circle – Dan Sfera interviews James Sapirstein Video 19 October 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 12 October 
New to the Street: Jayne King interviews James Sapirstein Video 01 October 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 28 September 
AzurRx to Acquire First Wave Bio for $229m Article 14 September 
AzurRx Carves Out Slice of IBD Market in $229 Million Buyout | BioSpace Article 13 September 
AzurRx boosts GI pipeline through First Wave buyout worth up to $229M | FierceBiotech Article 13 September 
Serial entrepreneur Gary Glick sells another one of his startups for $290M — this time to an unlikely buyer – Endpoints News (endpts.com) Article 13 September 
AzurRx BioPharma Acquires First Wave Bio Inc. - Contract Pharma Article 13 September 
AzurRx Carves Out Slice of IBD Market in $229 Million Buyout Article 13 September 
AzurRx boosts GI pipeline through First Wave buyout worth up to $229M Article  13 September
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 07 September 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 12 August 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 26 July 
National Public Radio (NPR) – KERA: Sam Baker interviews AzurRx COVID-GI clinical trial principal investigator Dr. Salma Saiger – “It’s Not Just A Respiratory Disease: How COVID Can Impact Your Gut” Podcast 19 July 
The Clinical Trials Guru – with Dan Sfera and James Sa Video 09 July 
Enhancing Human Life – with James Sapirstein and James Pennington Video 22 June 
New to the Street Video 13 June 
Healthcheck (WFAA-ABC Dallas/Ft. Worth): Sonia Azad discusses COVID-GI infections and the AzurRx Reservoir clinical trial with Dr. Salma Saiger Video 10 June 
The Big Biz ShowThe Big Biz Show - Bob “Sully” Sullivan interviews James Sapirstein Video 10 June 
Enhancing Human Life - with James Sapirstein and Douglas Jensen Video 9 June
Enhancing Human Life - with James Sapirstein and Douglas Jensen Podcast 9 June
WBAP/KLIF Dallas: Katrina Boonzaier interviews Dr. Salma Saiger about COVID-GI infections and the initiation of AzurRx’s Reservoir clinical trial. Article 4 June
The Big Biz Show - Bob “Sully” Sullivan interviews James Sapirstein Video 17 May
Investor Summit Group Q2 Virtual Summit Video 17 May
New to the Street Video  14 May
The Big Biz Show Video 3 May
Global Business Reports Article 24 March
H.C. Wainwright Fireside Chat Video 22 March
The Fly Article 15 March
Health Professional Radio: “COVID-19 Infections of the GI Tract and the Long Haul Phenomenon” Podcast 8 March
Attacking COVID-19 Virus Hiding in the Gastrointestinal Tract of Long-Haulers with James Sapirstein AzurRx BioPharma on Empowered Patient Podcast with Karen Jagoda Podcast 15 February

 
2020

 

TitleFormatDate
 Newsmax ” National Report” with Shaun Kraisman & Emma Rechenberg  Video  30 December 
 Newsmax “American Agenda” with Bob Sellers  Video 29 December 
 Stock2Me Podcast Featuring AzurRx Biopharma Inc. President & CEO James Sapirstein   Podcast 24 November 
 NTD “America is Talking” with Cindy Drukier  Video  12 November 
 TD Ameritrade Network “The Watch List” with Shawn Cruz   Video 02 November 
The Richmond Club Video 20 June
U.S. Biopharmaceuticals 2020 Report Article 4 June
Stock News Now (SNN) Live Video 19 May
Innovators with Jane King (LilaMax Media) Video 18 May
AzurRx Biopharma in the Age of COVID-19 - Q&A with CEO James Sapirstein - April 21, 2020 Video 21 April

logo ICO

CONTACT

777 Yamato Road
Suite 502
Boca Raton, FL 33431
(561) 589-7020

SOCIAL MEDIA